Earlyand late-onset fetal growth restriction: differential diagnosis based on proand antioxidant system markers


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To investigate pro- and antioxidant system parameters in early- and late-onset fetal growth restriction. Materials and methods. The study included 82patients: the main group consisted of 41 women whose pregnancies were complicated by fetal growth restriction and the control group included 41 women without fetal growth restriction. The main group was divided into two subgroups. Subgroup Ia consisted of 20 pregnant women with early-onset fetal growth restriction (manifested before 34 weeks’ gestation), subgroup Ib included 21 patients with late-onset fetal growth restriction (manifested after 34 weeks’ gestation). Maternal plasma pro- and antioxidant system markers were evaluated using spectrophotometry, polarography and Western blot analysis. Results. A significant increase in oxidative stress level was observed in early-onset fetal growth restriction subgroup, whereas there was a decrease in late-onset fetal growth restriction subgroup compared to the controls. Logistic regression model was developed to differentiate early- and late-onset fetal growth restriction using maternal plasma pro- and antioxidant system parameters. Conclusion. Maternal plasma pro- and antioxidant system markers can be used in differential diagnosis of early-and late-onset fetal growth restriction after 34 weeks’ gestation.

Full Text

Restricted Access

About the authors

Maria B. Ganichkina

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: mariaganichkina@yandex.ru
graduate student

Mikhail Yu. Vysokikh

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: m_vysokikh@oparina4.ru
PhD, the Head of mitochondrial medicine research group

Victor L. Tyutyunnik

European Medical Center Maternity Hospital

Email: tioutiounnik@mail.ru
PhD, MD, deputy head doctor

Vitaliy V. Chagovets

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: v_chagovets@oparina4.ru
PhD, senior researcher of Laboratory of Proteomics and Metabolomics of Human Reproduction, Department of Systems Biology in Reproduction

Natalia E. Kan

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia; European Medical Center Maternity Hospital

Email: kan-med@mail.ru
PhD, MD, head doctor of the Perinatal Center of European Medical Center, Professor of the Department of Obstetrics and Gynecology

References

  1. Стрижаков А.Н., Игнатко И.В., Тимохина Е.В., Белоцерковцева Л.Д. Синдром задержки роста плода. Патогенез. Диагностика. Лечение. Акушерская тактика. М.: ГЭОТАР-Медиа; 2014. 120 с.
  2. Anderson N.H., Sadler L.C., Stewart A.W., McCowan L.M.E. Maternal and pathological pregnancy characteristics in customised birthweight centiles and identification of at-risk small-for-gestational-age infants: a retrospective cohort study. BJOG. 2012; 119(7): 848-56. https://dx.doi.org/10.1111/j.1471-0528.2012.03313.x.
  3. Gardosi J., Madurasinghe V., Williams M., Malik A., Francis A. Maternal and fetal risk factors for stillbirth: population based study. BMJ. 2013; 346: f108. https:// dx.doi.org/10.1136/bmj.f108.
  4. Mayer C., Joseph K.S. Fetal growth: a review of terms, concepts and issues relevant to obstetrics. Ultrasound Obstet. Gynecol. 2013; 41(2): 136-45. https:// dx.doi.org/10.1002/uog.11204.
  5. De Onis M., Blossner M., Villar J. Levels and patterns of intrauterine growth retardation in developing countries. Eur. J. Clin. Nutr. 1998; 52(Suppl. 1): S5-15.
  6. Макаров И.О., Юдина Е.В., Боровкова Е.И. Задержка роста плода. Врачебная тактика. Учебное пособие. 3-е изд. М.: МЕДпресс-информ, 2016; 56 с.
  7. Crovetto F., Crispi F., Scazzocchio E., Mercade I., Meier E., Figueras F. et al. First-trimester screening for early and late small-for-gestational-age neonates using maternal serum biochemistry, blood pressure and uterine artery Doppler. Ultrasound Obstet. Gynecol. 2014; 43(1): 34-40. https://dx.doi.org/10.1002/ uog.12537.
  8. Spinillo A., Gardella B., Bariselli S., Alfei A., Silini E., Dal Bello B. Placental histopathological correlates of umbilical artery Doppler velocimetry in pregnancies complicated by fetal growth restriction. Prenat. Diagn. 2012; 32(13): 1263-72. https://dx.doi.org/10.1002/pd.3988.
  9. Llurba E., Turan O., Kasdaglis T., Harman C.R., Baschat A.A. Emergence of late-onset placental dysfunction: relationship to the change in uterine artery blood flow resistance between the first and third trimesters. Am. J. Perinatol. 2013; 30(6): 505-12. https://dx.doi.org/10.1055/s-0032-1329181.
  10. Jacobsson B., Ahlin K., Francis A., Hagberg G., Hagberg H., Gardosi J. Cerebral palsy and restricted growth status at birth: population-based case-control study. BJOG. 2008; 115(10): 1250-5. https://dx.doi.org/10.1111/j.1471-0528.2008.01827.x.
  11. Biri A., Bozkurt N., Turp A., Kavutcu M., Himmetoglu O., Durak I. Role of oxidative stress in intrauterine growth restriction. Gynecol. Obstet. Invest. 2007; 64(4): 187-92. https://dx.doi.org/10.1159/000106488.
  12. Longini M., Perrone S., Kenanidis A., Vezzosi P., Marzocchi B., Petraglia F. et al. Isoprostanes in amniotic fluid: a predictive marker for fetal growth restriction in pregnancy. Free Radic. Biol. Med. 2005; 38(11): 1537-41. https://dx.doi. org/10.1016/j.freeradbiomed.2005.02.017.
  13. Kamath U., Rao G., Kamath S.U., Rai L. Maternal and fetal indicators of oxidative stress during intrauterine growth retardation (IUGR). Indian J. Clin. Biochem. 2006; 21(1): 111-5. https://dx.doi.org/ 10.1007/BF02913077.
  14. Mert I., Oruc A.S., Yuksel S., Cakar E.S., Buyukkagnici U., Karaer A. Role of oxidative stress in preeclampsia and intrauterine growth restriction. J. Obstet. Gynaecol. Res. 2012; 38(4): 658-64. https://dx.doi.org/10.1111/j.1447-0756.2011.01771.x.
  15. Toescu V., Nuttall S.L., Martin U., Kendall M.J., Dunne F. Oxidative stress and normal pregnancy. Clin. Endocrinol. (Oxf). 2002; 57(5): 609-13. https:// dx.doi.org/10.1046/j.1365-2265.2002.01638.x.
  16. Duhig K., Chappell L.C., Shennan A.H. Oxidative stress in pregnancy and reproduction. Obstet. Med. 2016; 9(3): 113-6. https:// dx.doi.org/10.1177/1753495X16648495.
  17. Хачатрян З.В., Кан Н.Е., Красный А.М., Садекова А.А., Куревлев С.В., Тютюнник В.Л. Метилирование генов в плаценте при задержке роста плода. Акушерство и гинекология. 2019; 12: 54-8.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies